Suppr超能文献

妊娠恶心和呕吐及妊娠剧吐的初级和二级保健临床管理:基于人群的研究。

Clinical management of nausea and vomiting in pregnancy and hyperemesis gravidarum across primary and secondary care: a population-based study.

机构信息

Division of Epidemiology & Public Health, University of Nottingham, Nottingham, UK.

Women's Health Academic Centre, Guy's & St Thomas' Foundation Trust, St Thomas' Hospital, London, UK.

出版信息

BJOG. 2019 Sep;126(10):1201-1211. doi: 10.1111/1471-0528.15662. Epub 2019 Mar 27.

Abstract

OBJECTIVES

To assess how nausea and vomiting in pregnancy (NVP) and hyperemesis gravidarum (HG) are managed and treated across primary and secondary care.

DESIGN

Population-based pregnancy cohort.

SETTING

Medical records (CPRD-GOLD) from England.

POPULATION

417 028 pregnancies during 1998-2014.

METHODS

Proportions of pregnancies with recorded NVP/HG diagnoses, primary care treatment, and hospital admissions were calculated. Multinomial logistic regression was employed to estimate adjusted relative risk ratios (aRRRs) with 99% confidence intervals (CIs) for the association between NVP/HG management paths and maternal characteristics.

MAIN OUTCOME MEASURES

NVP/HG diagnoses, treatments, and hospital admissions.

RESULTS

Overall prevalence of clinically recorded NVP/HG was 9.1%: 2.1% had hospital admissions, 3.4% were treated with antiemetics in primary care only, and 3.6% had only recorded diagnoses. Hospital admissions and antiemetic prescribing increased continuously during 1998-2013 (trend P < 0.001). Younger age, deprivation, Black/Asian/mixed ethnicity, and multiple pregnancy were associated with NVP/HG generally across all levels, but associations were strongest for hospital admissions. Most comorbidities had patterns of association with NVP/HG levels. Among women with NVP/HG who had no hospital admissions, 49% were prescribed antiemetics, mainly from first-line treatment (21% prochlorperazine, 15% promethazine, 13% cyclizine) and metoclopramide (10%). Of those admitted, 38% had prior antiemetic prescriptions (34% first-line, 9% second-line, 1% third-line treatment).

CONCLUSION

Previous focus on hospital admissions has greatly underestimated the NVP/HG burden. Although primary care prescribing has increased, most women admitted to hospital have no antiemetics prescribed before this. An urgent call is made to assess whether admissions could be prevented with better primary care recognition and timely treatment.

TWEETABLE ABSTRACT

The NVP/HG burden is increasing over time and management optimisation should be high priority to help reduce hospital admissions.

摘要

目的

评估在初级和二级保健中,妊娠恶心呕吐(NVP)和妊娠剧吐(HG)的管理和治疗方法。

设计

基于人群的妊娠队列。

设置

来自英格兰的医疗记录(CPRD-GOLD)。

人群

1998 年至 2014 年期间的 417 028 例妊娠。

方法

计算有记录的 NVP/HG 诊断、初级保健治疗和住院治疗的妊娠比例。采用多变量逻辑回归估计 NVP/HG 管理路径与产妇特征之间的关联的调整后相对风险比(aRRR)及其 99%置信区间(CI)。

主要结局指标

NVP/HG 诊断、治疗和住院。

结果

临床记录的 NVP/HG 总患病率为 9.1%:2.1%住院,3.4%仅在初级保健中用止吐药治疗,3.6%仅记录诊断。1998 年至 2013 年期间,住院治疗和止吐药处方呈持续增加趋势(趋势 P <0.001)。年轻、贫困、黑人/亚洲/混血和多胎妊娠与各级 NVP/HG 均普遍相关,但与住院治疗的相关性最强。大多数合并症与 NVP/HG 水平有一定的关联模式。在没有住院的 NVP/HG 妇女中,49%开具了止吐药,主要来自一线治疗(21%丙氯拉嗪、15%苯海拉明、13%氯丙嗪)和甲氧氯普胺(10%)。在入院的患者中,38%有之前开具的止吐药处方(34%一线治疗,9%二线治疗,1%三线治疗)。

结论

以前对住院治疗的关注极大地低估了 NVP/HG 的负担。尽管初级保健的处方有所增加,但大多数住院的妇女在此之前都没有开具止吐药。现在急需评估,是否可以通过更好的初级保健识别和及时治疗来预防住院。

推特摘要

NVP/HG 的负担随着时间的推移而增加,优化管理应该是当务之急,以帮助减少住院治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验